Self-regulatory role of 4-hydroxynonenal in signaling for stress-induced programmed cell death

Free Radical Biology and Medicine

Volumn 45, Issue 2, 2008, Pages 111-118

  Awasthi, Yogesh C ^a   Sharma, Rajendra ^a   Sharma, Abha ^a   Yadav, Sushma ^a   Singhal, Sharad S ^a   Chaudhary, Pankaj ^a   Awasthi, Sanjay ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

4 Hydroxynonenal; Apoptosis; Cell cycle signalling; Daxx; Fas; Heat shock factor 1; P53

Indexed keywords

4 HYDROXYNONENAL; DAXX PROTEIN; FAS ANTIGEN; HYDROGEN PEROXIDE; MEMBRANE RECEPTOR; PROTEIN P53; TRANSCRIPTION FACTOR;

APOPTOSIS; BIOLOGICAL ACTIVITY; CELL ACTIVITY; CELL FUNCTION; CYTOPLASM; HUMAN; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ALDEHYDES; ANIMALS; ANTIGENS, CD95; APOPTOSIS; HUMANS; HYDROGEN PEROXIDE; NUCLEAR PROTEINS; OXIDANTS; OXIDATIVE STRESS; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 44649173705     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2008.04.007     Document Type: Review

References (121)

1. Esterbauer H., Schaur R.J., and Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 11 (1991) 81-128
2. Awasthi Y.C., Yang Y., Tiwari N.K., Patrick B., Sharma A., Li J., and Awasthi S. Regulation of 4-hydroxynonenal-mediated signaling by glutathione S-transferases. Free Radic. Biol. Med. 37 (2004) 607-619
3. Awasthi Y.C., Ansari G.A., and Awasthi S. Regulation of 4-hydroxynonenal mediated signaling by glutathione S-transferases. Methods Enzymol. 401 (2005) 379-407
4. Awasthi Y.C., Sharma R., Cheng J.Z., Yang Y., Sharma A., Singhal S.S., and Awasthi S. Role of 4-hydroxynonenal in stress-mediated apoptosis signaling. Mol. Aspects Med. 24 (2003) 219-230
5. Sampey B.P., Stewart B.J., and Petersen D.R. Ethanol-induced modulation of hepatocellular extracellular signal-regulated kinase-1/2 activity via 4-hydroxynonenal. J. Biol. Chem. 282 (2007) 1925-1937
6. Choudhary S., Xiao T., Vergara L.A., Srivastava S., Nees D., Piatigorsky J., and Ansari N.H. Role of aldehyde dehydrogenase isozymes in the defense of rat lens and human lens epithelial cells against oxidative stress. Invest. Ophthalmol. Vis. Sci. 46 (2005) 259-267
7. Cheng J.Z., Sharma R., Yang Y., Singhal S.S., Sharma A., Saini M.K., Singh S.V., Zimniak P., Awasthi S., and Awasthi Y.C. Accelerated metabolism and exclusion of 4-hydroxynonenal through induction of RLIP76 and hGST5.8 is an early adaptive response of cells to heat and oxidative stress. J. Biol. Chem. 276 (2001) 41213-41223
8. Yang Y., Sharma R., Cheng J.Z., Saini M.K., Ansari N.H., Andley U.P., Awasthi S., and Awasthi Y.C. Protection of HLE B-3 cells against hydrogen peroxide- and naphthalene-induced lipid peroxidation and apoptosis by transfection with hGSTA1 and hGSTA2. Invest. Ophthalmol. Vis. Sci. 43 (2002) 434-445
9. Yang Y., Sharma A., Sharma R., Patrick B., Singhal S.S., Zimniak P., Awasthi S., and Awasthi Y.C. Cells preconditioned with mild, transient UVA irradiation acquire resistance to oxidative stress and UVA-induced apoptosis: role of 4-hydroxynonenal in UVA-mediated signaling for apoptosis. J. Biol. Chem. 278 (2003) 41380-41388
10. Brigelius-Flohé R., Friedrichs B., Maurer S., Schultz M., and Streicher R. Interleukin-1-induced nuclear factor kappa B activation is inhibited by overexpression of phospholipid hydroperoxide glutathione peroxidase in a human endothelial cell line. Biochem. J. 328 Pt 1 (1997) 199-203
11. Singhal S.S., Awasthi Y.C., and Awasthi S. Regression of melanoma in a murine model by RLIP76 depletion. Cancer Res. 66 (2006) 2354-2360
12. Singhal S.S., Singhal J., Yadav S., Dwivedi S., Boor P.J., Awasthi Y.C., and Awasthi S. Regression of lung and colon cancer xenografts by depleting or inhibiting RLIP76 (RALBP1). Cancer Res. 67 (2007) 4382-4389
13. Ramana K.V., Bhatnagar A., Srivastava S., Yadav U.C., Awasthi S., Awasthi Y.C., and Srivastava S.K. Mitogenic responses of vascular smooth muscle cells to lipid peroxidation-derived aldehyde 4-hydroxy-trans-2-nonenal (HNE): role of aldose reductase-catalyzed reduction of the HNE-glutathione conjugates in regulating cell growth. J. Biol. Chem. 281 (2006) 17652-17660
14. Ramana K.V., Willis M.S., White M.D., Horton J.W., DiMaio J.M., Srivastava D., Bhatnagar A., and Srivastava S.K. Endotoxin-induced cardiomyopathy and systemic inflammation in mice is prevented by aldose reductase inhibition. Circulation 114 (2006) 1838-1846
15. Li J., Sharma R., Patrick B., Sharma A., Jeyabal P.V., Reddy P.M., Saini M.K., Dwivedi S., Dhanani S., Ansari N.H., Zimniak P., Awasthi S., and Awasthi Y.C. Regulation of CD95 (Fas) expression and Fas-mediated apoptotic signaling in HLE B-3 cells by 4-hydroxynonenal. Biochemistry 45 (2006) 12253-12264
16. Sharma R., Sharma A., Dwivedi S., Zimniak P., Awasthi S., and Awasthi Y.C. 4-Hydroxynonenal self limits Fas-mediated DISC independent apoptosis by promoting export of Daxx from nucleus to cytosol and its binding to Fas. Biochemistry 47 (2008) 143-156
17. Leonarduzzi G., Robbesyn F., and Poli G. Signaling kinases modulated by 4-hydroxynonenal. Free Radic. Biol. Med. 37 (2004) 1694-1702
18. Dianzani M.U. 4-Hydroxynonenal from pathology to physiology. Mol. Aspects Med. 24 (2003) 263-272
19. Negre-Salvayre A., Vieira O., Escargueil-Blanc I., and Salvayre R. Oxidized LDL and 4-hydroxynonenal modulate tyrosine kinase receptor activity. Mol. Aspects Med. 24 (2003) 251-261
20. Nakashima I., Anwarul A.A., Takeda K., Kawamoto Y., Kato M., and Suzuki H. 4-Hydroxynonenal triggers multistep signal transduction cascades for suppression of cellular functions. Mol. Aspects Med. 24 (2003) 231-238
21. Zarkovic N. 4-hydroxynonenal as a bioactive marker of pathophysiological processes. Mol. Aspects Med. 24 (2003) 281-291
22. Uchida K. 4-Hydroxy-2-nonenal: a product and mediator of oxidative stress Prog. Lipid Res. 42 (2003) 318-343
23. Dwivedi S., Sharma A., Patrick B., Sharma R., and Awasthi Y.C. Role of 4- hydroxynonenal and its metabolites in signaling. Redox Rep. 12 (2007) 4-10
24. Kutuk O., and Basaga H. Apoptosis signaling by 4-hydroxynonenal: a role for JNK-c-Jun/AP-1 pathway. Redox Rep. 12 (2007) 30-34
25. Jacobs A.T., and Marnett L.J. Heat shock factor-1 attenuates 4-hydroxynonenal-mediated apoptosis: critical role for HSP70 induction and stabilization of Bcl-XL. J. Biol. Chem. 282 (2007) 33412-33420
26. Zhang H., Liu H., Dickinson D.A., Liu R.M., Postlethwait E.M., Laperche Y., and Forman H.J. gamma-glutamyl transpeptidase is induced by 4-hydroxynonenal via EpRE/Nrf2 signaling in rat epithelial type II cells. Free Radic. Biol. Med. 40 (2006) 1281-1292
27. Vindis C., Escargueil-Blanc I., Elbaz M., Marcheix B., Grazide M.H., Uchida K., Salvayre R., and Nègre-Salvayre A. Desensitization of platelet-derived growth factor receptor-beta by oxidized lipids in vascular cells and atherosclerotic lesions: prevention by aldehyde scavengers. Circ. Res. 98 (2006) 785-792
28. Fang J., and Holmgren A. Inhibition of thioredoxin and thioredoxin reductase by 4-hydroxy-2-nonenal in vitro and in vivo. J. Am. Chem. Soc. 128 (2006) 1879-1885
29. Vizio B., Poli G., Chiarpotto E., and Biasi F. 4-Hydroxynonenal and TGF-beta1 concur in inducing antiproliferative effects on the CaCo-2 human colon adenocarcinoma cell line. Biofactors 24 (2005) 237-246
30. Sunjic S.B., Cipak A., Rabuzin F., Wildburger R., and Zarkovic N. The influence of 4-hydroxy-2-nonenal on proliferation, differentiation and apoptosis of human osteosarcoma cells. Biofactors 24 (2005) 141-148
31. Sharma R., Yang Y., Sharma A., Awasthi S., and Awasthi Y.C. Antioxidant role of glutathione S-transferases: protection against oxidant toxicity and regulation of stress-mediated apoptosis. Antioxid. Redox Signal. 6 (2004) 289-300
32. Uchida K., Shiraishi M., Naito Y., Torii Y., Nakamura Y., and Osawa T. Activation of stress signaling pathways by the end product of lipid peroxidation. 4-hydroxy-2-nonenal is a potential inducer of intracellular peroxide production. J. Biol. Chem. 274 (1999) 2234-2242
33. Castello L., Marengo B., Nitti M., Froio T., Domenicotti C., Biasi F., Leonarduzzi G., Pronzato M.A., Marinari U.M., Poli G., and Chiarpotto E. 4-Hydroxynonenal signaling to apoptosis in isolated rat hepatocytes: the role of PKC-delta. Biochim. Biophys. Acta 1737 (2005) 83-93
34. West J.D., and Marnett L.J. Alterations in gene expression induced by the lipid peroxidation product, 4-hydroxy-2-nonenal. Chem. Res. Toxicol. 18 (2005) 1642-1653
35. Chen Z.H., Saito Y., Yoshida Y., Sekine A., Noguchi N., and Niki E. Hydroxynonenal induces adaptive response and enhances PC12 cell tolerance primarily through induction of thioredoxin reductase 1 via activation of Nrf2. J. Biol. Chem. 280 (2005) 41921-41927
36. Patrick B., Li J., Jeyabal P.V., Reddy P.M., Yang Y., Sharma R., Sinha M., Luxon B., Zimniak P., Awasthi S., and Awasthi Y.C. Depletion of 4-hydroxynonenal in hGSTA4-transfected HLE B-3 cells results in profound changes in gene expression. Biochem. Biophys. Res. Commun. 334 (2005) 425-432
37. Iles K.E., Dickinson D.A., Wigley A.F., Welty N.E., Blank V., and Forman H.J. HNE increases HO-1 through activation of the ERK pathway in pulmonary epithelial cells. Free Radic. Biol. Med. 39 (2005) 355-364
38. Tamagno E., Parola M., Bardini P., Piccini A., Borghi R., Guglielmotto M., Santoro G., Davit A., Danni O., Smith M.A., Perry G., and Tabaton M. Beta-site APP cleaving enzyme up-regulation induced by 4-hydroxynonenal is mediated by stress-activated protein kinases pathways. J. Neurochem. 92 (2005) 628-636
39. Moneypenny C.G., and Gallagher E.P. 4-Hydroxynonenal inhibits cell proliferation and alters differentiation pathways in human fetal liver hematopoietic stem cells. Biochem. Pharmacol. 69 (2005) 105-112
40. Kumagai T., Matsukawa N., Kaneko Y., Kusumi Y., Mitsumata M., and Uchida K. A lipid peroxidation-derived inflammatory mediator: identification of 4-hydroxy-2-nonenal as a potential inducer of cyclooxygenase-2 in macrophages. J. Biol. Chem. 279 (2004) 48389-48396
41. Uchida K., and Kumagai T. 4-hydroxy-2-nonenal as a COX-2 inducer. Mol. Aspects Med. 24 (2003) 213-218
42. Kumagai T., Kawamoto Y., Nakamura Y., Hatayama I., Satoh K., Osawa T., and Uchida K. 4-hydroxy-2-nonenal, the end product of lipid peroxidation, is a specific inducer of cyclooxygenase-2 gene expression. Biochem. Biophys. Res. Commun. 273 (2000) 437-441
43. Kikuta K., Masamune A., Satoh M., Suzuki N., and Shimosegawa T. 4-hydroxy-2,3-nonenal activates activator protein-1 and mitogen-activated protein kinases in rat pancreatic stellate cells. World J. Gastroenterol. 10 (2004) 2344-2351
44. Dozza B., Smith M.A., Perry G., Tabaton M., and Strocchi P. Regulation of glycogen synthase kinase-3beta by products of lipid peroxidation in human neuroblastoma cells. J. Neurochem. 89 (2004) 1224-1232
45. Sharma R., Brown D., Awasthi S., Yang Y., Sharma A., Patrick B., Saini M.K., Singh S.P., Zimniak P., Singh S.V., and Awasthi Y.C. Transfection with 4-hydroxynonenal-metabolizing glutathione S-transferase isozymes leads to phenotypic transformation and immortalization of adherent cells. Eur. J. Biochem. 271 (2004) 1690-1701
46. West J.D., Ji C., Duncan S.T., Amarnath V., Schneider C., Rizzo C.J., Brash A.R., and Marnett L.J. Induction of apoptosis in colorectal carcinoma cells treated with 4-hydroxy-2-nonenal and structurally related aldehydic products of lipid peroxidation. Chem. Res. Toxicol. 17 (2004) 453-462
47. Cheng J.Z., Singhal S.S., Sharma A., Saini M., Yang Y., Awasthi S., Zimniak P., and Awasthi Y.C. Transfection of mGSTA4 in HL-60 cells protects against 4-hydroxynonenal-induced apoptosis by inhibiting JNK-mediated signaling. Arch. Biochem. Biophys. 392 (2001) 197-207
48. Sharma R., Yang Y., Sharma A., Dwivedi S., Popov V.L., Boor P.J., Singhal S.S., Awasthi S., and Awasthi Y.C. Mechanisms and physiological significance of the transport of the glutathione conjugate of 4-hydroxynonenal in human lens epithelial cells. Invest. Ophthalmol. Vis. Sci. 44 (2003) 3438-3449
49. 2+ current by 4-hydroxynonenal in dentate granule cells. Biol. Pharm. Bull. 27 (2004) 174-179
50. Zamara E., Novo E., Marra F., Gentilini A., Romanelli R.G., Caligiuri A., Robino G., Tamagno E., Aragno M., Danni O., Autelli R., Colombatto S., Dianzani M.U., Pinzani M., and Parola M. 4-Hydroxynonenal as a selective pro-fibrogenic stimulus for activated human hepatic stellate cells. J. Hepatol. 40 (2004) 60-68
51. Parola M., Robino G., Marra F., Pinzani M., Bellomo G., Leonarduzzi G., Chiarugi P., Camandola S., Poli G., Waeg G., Gentilini P., and Dianzani M.U. HNE interacts directly with JNK isoforms in human hepatic stellate cells. J. Clin. Invest. 102 (1998) 1942-1950
52. Liu W., Akhand A.A., Takeda K., Kawamoto Y., Itoigawa M., Kato M., Suzuki H., Ishikawa N., and Nakashima I. Protein phosphatase 2A-linked and -unlinked caspase-dependent pathways for downregulation of Akt kinase triggered by 4-hydroxynonenal. Cell Death Differ. 10 (2003) 772-781
53. Bruckner S.R., Perry G., and Estus S. 4-Hydroxynonenal contributes to NGF withdrawal-induced neuronal apoptosis. J. Neurochem. 85 (2003) 999-1005
54. Donath B., Fischer C., Page S., Prebeck S., Jilg N., Weber M., da Costa C., Neumeier D., Miethke T., and Brand K. Chlamydia pneumoniae activates IKK/I kappa B-mediated signaling, which is inhibited by 4-HNE and following primary exposure. Atherosclerosis 165 (2002) 79-88
55. Dickinson D.A., Iles K.E., Watanabe N., Iwamoto T., Zhang H., Krzywanski D.M., and Forman H.J. 4-Hydroxynonenal induces glutamate cysteine ligase through JNK in HBE1 cells. Free Radic. Biol. Med. 33 (2002) 974
56. Tsukagoshi H., Kawata T., Shimizu Y., Ishizuka T., Dobashi K., and Mori M. 4-Hydroxy-2-nonenal enhances fibronectin production by IMR-90 human lung fibroblasts partly via activation of epidermal growth factor receptor-linked extracellular signal-regulated kinase p44/42 pathway. Toxicol. Appl. Pharmacol. 184 (2002) 127-135
57. Ayalasomayajula S.P., and Kompella U.B. Induction of vascular endothelial growth factor by 4-hydroxynonenal and its prevention by glutathione precursors in retinal pigment epithelial cells. Eur. J. Pharmacol. 449 (2002) 213-220
58. Nitti M., Domenicotti C., d'Abramo C., Assereto S., Cottalasso D., Melloni E., Poli G., Biasi F., Marinari U.M., and Pronzato M.A. Activation of PKC-beta isoforms mediates HNE-induced MCP-1 release by macrophages. Biochem. Biophys. Res. Commun. 294 (2002) 547-552
59. Hattori Y., Hattori S., and Kasai K. 4-Hydroxynonenal prevents NO production in vascular smooth muscle cells by inhibiting nuclear factor-kappa B-dependent transcriptional activation of inducible NO synthase. Arterioscler. Thromb. Vasc. Biol. 21 (2001) 1179-1183
60. Ruef J., Moser M., Bode C., Kübler W., and Runge M.S. 4-Hydroxynonenal induces apoptosis, NF-kappaB-activation and formation of 8-isoprostane in vascular smooth muscle cells. Basic Res. Cardiol. 96 (2001) 143-150
61. Song B.J., Soh Y., Bae M., Pie J., Wan J., and Jeong K. Apoptosis of PC12 cells by 4-hydroxy-2-nonenal is mediated through selective activation of the c-Jun N-terminal protein kinase pathway. Chem. Biol. Interact. 130-132 (2001) 943-954
62. Camandola S., Poli G., and Mattson M.P. The lipid peroxidation product 4-hydroxy-2,3-nonenal inhibits constitutive and inducible activity of nuclear factor kappa B in neurons. Brain Res. Mol. Brain Res. 85 (2000) 53-60
63. Robino G., Parola M., Marra F., Caligiuri A., De Franco R.M., Zamara E., Bellomo G., Gentilini P., Pinzani M., and Dianzani M.U. Interaction between 4-hydroxy-2,3-alkenals and the platelet-derived growth factor-beta receptor. Reduced tyrosine phosphorylation and downstream signaling in hepatic stellate cells. J. Biol. Chem. 275 (2000) 40561-40567
64. Liu W., Akhand A.A., Kato M., Yokoyama I., Miyata T., Kurokawa K., Uchida K., and Nakashima I. 4-hydroxynonenal triggers an epidermal growth factor receptor-linked signal pathway for growth inhibition. J. Cell Sci. 112 Pt 14 (1999) 2409-2417
65. Chiarpotto E., Domenicotti C., Paola D., Vitali A., Nitti M., Pronzato M.A., Biasi F., Cottalasso D., Marinari U.M., Dragonetti A., Cesaro P., Isidoro C., and Poli G. Regulation of rat hepatocyte protein kinase C beta isoenzymes by the lipid peroxidation product 4-hydroxy-2,3-nonenal: a signaling pathway to modulate vesicular transport of glycoproteins. Hepatology 29 (1999) 1565-1572
66. Kreuzer T., Grube R., Wutte A., Zarkovic N., and Schaur R.J. 4-Hydroxynonenal modifies the effects of serum growth factors on the expression of the c-fos proto-oncogene and the proliferation of HeLa carcinoma cells. Free Radic. Biol. Med. 25 (1998) 42-49
67. Blanc E.M., Kelly J.F., Mark R.J., Waeg G., and Mattson M.P. 4-Hydroxynonenal, an aldehydic product of lipid peroxidation, impairs signal transduction associated with muscarinic acetylcholine and metabotropic glutamate receptors: possible action on G alpha(q/11). J. Neurochem. 69 (1997) 570-580
68. 2+ influx in isolated rat hepatocytes. Biochem. Biophys. Res. Commun. 218 (1996) 772-776
69. Martínez M.C., Bosch-Morell F., Raya A., Romá J., Aldasoro M., Vila J., Lluch S., and Romero F.J. 4-Hydroxynonenal, a lipid peroxidation product, induces relaxation of human cerebral arteries. J. Cereb. Blood Flow Metab. 14 (1994) 693-696
70. Curzio M., Torrielli M.V., Giroud J.P., Esterbauer H., and Dianzani M.U. Neutrophil chemotactic responses to aldehydes. Res. Commun. Chem. Pathol. Pharmacol. 36 (1982) 463-476
71. Paradisi L., Panagini C., Parola M., Barrera G., and Dianzani M.U. Effects of 4-hydroxynonenal on adenylate cyclase and 5′-nucleotidase activities in rat liver plasma membranes. Chem. Biol. Interact. 53 (1985) 209-217
72. Rossi M.A., Garramone A., and Dianzani M.U. Stimulation of phospholipase C activity by 4-hydroxynonenal; influence of GTP and calcium concentration. Int. J. Tissue React. 10 (1988) 321-357
73. Cajone F., and Bernelli-Zazzera A. The action of 4-hydroxynonenal on heat shock gene expression in cultured hepatoma cells. Free Radic. Res. Commun. 7 (1989) 189-194
74. Fazio V.M., Barrera G., Martinotti S., Farace M.G., Giglioni B., Frati L., Manzari V., and Dianzani M.U. 4-Hydroxynonenal, a product of cellular lipid peroxidation, which modulates c-myc and globin gene expression in K562 erythroleukemic cells. Cancer Res. 52 (1992) 4866-4871
75. Barrera G., Pizzimenti S., Muraca R., Barbiero G., Bonelli G., Baccino F.M., Fazio V.M., and Dianzani M.U. Effect of 4-Hydroxynonenal on cell cycle progression and expression of differentiation-associated antigens in HL-60 cells. Free Radic. Biol. Med. 20 (1996) 455-462
76. Camandola S., Scavazza A., Leonarduzzi G., Biasi F., Chiarpotto E., Azzi A., and Poli G. Biogenic 4-hydroxy-2-nonenal activates transcription factor AP-1 but not NF-kappa B in cells of the macrophage lineage. Biofactors 6 (1997) 173-179
77. Sharma A., Patrick B., Li J., Sharma R., Jeyabal P.V., Reddy P.M., Awasthi S., and Awasthi Y.C. Glutathione S-transferases as antioxidant enzymes: small cell lung cancer (H69) cells transfected with hGSTA1 resist doxorubicin-induced apoptosis. Arch. Biochem. Biophys. 452 (2006) 165-173
78. Singhal S.S., Singhal J., Sharma R., Singh S.V., Zimniak P., Awasthi Y.C., and Awasthi S. Role of RLIP76 in lung cancer doxorubicin resistance. I. The ATPase activity of RLIP76 correlates with doxorubicin and 4-hydroxynonenal resistance in lung cancer cells. Int. J. Oncol. 22 (2003) 365-375
79. Awasthi S., Singhal S.S., Singhal J., Cheng J., Zimniak P., and Awasthi Y.C. Role of RLIP76 in lung cancer doxorubicin resistance. II. Doxorubicin transport in lung cancer by RLIP76. Int. J. Oncol. 22 (2003) 713-720
80. Awasthi S., Singhal S.S., Singhal J., Yang Y., Zimniak P., and Awasthi Y.C. Role of RLIP76 in lung cancer doxorubicin resistance. III. Anti-RLIP76 antibodies trigger apoptosis in lung cancer cells and synergistically increase doxorubicin cytotoxicity. Int. J. Oncol. 22 (2003) 721-732
81. Danial N.N., and Korsmeyer S.J. Cell death: critical control points. Cell 116 (2004) 205-219
82. Itoh N., Yonehara S., Ishii A., Yonehara M., Mizushima S., Sameshima M., Hase A., Seto Y., and Nagata S. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66 (1991) 233-243
83. Itoh N., and Nagata S. A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen. J. Biol. Chem. 268 (1993) 10932-10937
84. Suda T., Takahashi T., Golstein P., and Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75 (1993) 1169-1178
85. Quirk S.M., Porter D.A., Huber S.C., and Cowan R.G. Potentiation of Fas-mediated apoptosis of murine granulosa cells by interferon-gamma, tumor necrosis factor-alpha, and cycloheximide. Endocrinology 139 (1998) 4860-4869
86. Nagata S. Apoptosis by death factor. Cell 88 (1997) 355-365
87. Yang X., Khosravi-Far R., Chang H.Y., and Baltimore D. Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell 89 (1997) 1067-1076
88. Pluta A.F., Earnshaw W.C., and Goldberg I.G. Interphase-specific association of intrinsic centromere protein CENP-C with HDaxx, a death domain-binding protein implicated in Fas-mediated cell death. J. Cell Sci. 111 Pt 14 (1998) 2029-2041
89. Forman H.J., Dickinson D.A., and Iles K.E. HNE-signaling pathways leading to its elimination. Mol. Aspects Med. 24 (2003) 189-194
90. Chen L.Y., and Chen J.D. Daxx silencing sensitizes cells to multiple pathways. Mol. Cell Biol. 23 (2003) 7108-7121
91. Boehrer S., Nowak D., Hochmuth S., Kim S.Z., Trepohl B., Afkir A., Hoelzer D., Mitrou P.S., Weidmann E., and Chow K.U. Daxx overexpression in T-lymphoblastic Jurkat cells enhances caspase-dependent death receptor- and drug-induced apoptosis in distinct ways. Cell Signal. 17 (2005) 581-595
92. Salomoni P., and Khelifi A.F. Daxx: death or survival protein?. Trends Cell Biol. 16 (2006) 97-104
93. Levine A.J. p53, the cellular gatekeeper for growth and division. Cell 88 (1997) 323-331
94. Gottlieb T.M., and Oren M. p53 and apoptosis. Semin. Cancer Biol. 8 (1998) 359-368
95. Harris S.L., and Levine A.J. The p53 pathway: positive and negative feedback loops. Oncogene 24 (2005) 2899-2908
96. Shieh S.Y., Ikeda M., Taya Y., and Prives C. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91 (1997) 325-334
97. Siliciano J.D., Canman C.E., Taya Y., Sakaguchi K., Appella E., and Kastan M.B. DNA damage induces phosphorylation of the amino terminus of p53. Genes Dev. 11 (1997) 3471-3481
98. Canman C.E., Lim D.S., Cimprich K.A., Taya Y., Tamai K., Sakaguchi K., Appella E., Kastan M.B., and Siliciano J.D. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281 (1998) 1677-1679
99. Laurora S., Tamagno E., Briatore F., Bardini P., Pizzimenti S., Toaldo C., Reffo P., Costelli P., Dianzani M.U., Danni O., and Barrera G. 4-Hydroxynonenal modulation of p53 family gene expression in the SK-N-BE neuroblastoma cell line. Free Radic. Biol. Med. 38 (2005) 215-225
100. Meek D.W. Post-translational modification of p53. Semin. Cancer Biol. 5 (1994) 203-210
101. el-Deiry W.S., Tokino T., Velculescu V.E., Levy D.B., Parsons R., Trent J.M., Lin D., Mercer W.E., Kinzler K.W., and Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell 75 (1993) 817-825
102. Miyashita T., and Reed J.C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80 (1995) 293-299
103. Oren M. Relationship of p53 to the control of apoptotic cell death. Semin. Cancer Biol. 5 (1994) 221-227
104. Boellmann F., Guettouche T., Guo Y., Fenna M., Mnayer L., and Voellmy R. DAXX interacts with heat shock factor 1 during stress activation and enhances its transcriptional activity. Proc. Natl. Acad. Sci. USA 101 (2004) 41000-41005
105. Numazawa S., Ishikawa M., Yoshida A., Tanaka S., and Yoshida T. Atypical protein kinase C mediates activation of NF-E2-related factor 2 in response to oxidative stress. Am. J. Physiol. Cell Physiol. 285 (2003) C334-C342
106. Perlman R., Schiemann W.P., Brooks M.W., Lodish H.F., and Weinberg R. A TGF-beta-induced apoptosis is mediated by the adapter protein Daxx that facilitates JNK activation. Nat. Cell. Biol. 3 (2001) 708-714
107. Hollenbach A.D., Sublett J.E., McPherson C.J., and Grosveld G. The Pax3-FKHR oncoprotein is unresponsive to the Pax3-associated repressor hDaxx. EMBO J. 18 (1999) 3702-3711
108. Hu Y., and Mivechi N.F. HSF-1 interacts with Ral-binding protein 1 in a stress-responsive, multiprotein complex with HSP90 in vivo. J. Biol. Chem. 278 (2003) 17299-17306
109. Rossé C., L'Hoste S., Offner N., Picard A., and Camonis J. RLIP, an effector of the Ral GTPases, is a platform for Cdk1 to phosphorylate epsin during the switch off of endocytosis in mitosis. J. Biol. Chem. 278 (2003) 30597-30604
110. Vacaresse N., Vieira O., Robbesyn F., Jurgens G., Salvayre R., and Negre-Salvayre A. Phenolic antioxidants trolox and caffeic acid modulate the oxidized LDL-induced EGF-receptor activation. Br. J. Pharmacol. 132 (2001) 1777-1788
111. Uchida K., and Stadtman E.R. Selective cleavage of thioether linkage in proteins modified with 4-hydroxynonenal. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 5611-5615
112. Escargueil-Blanc I., Salvayre R., Vacaresse N., Jurgens G., Darblade B., Arnal J.F., Parthasarathy S., and Negre-Salvayre A. Mildly oxidized LDL induces activation of platelet-derived growth factor beta-receptor pathway. Circulation 104 (2001) 1814-1821
113. Yadav S., Zajac E., Singhal S.S., and Awasthi S. Linking stress-signaling, glutathione metabolism, signaling pathways and xenobiotic transporters. Cancer Metastasis Rev. 26 (2007) 59-69
114. Nakashima S., Morinaka K., Koyama S., Ikeda M., Kishida M., Okawa K., Iwamatsu A., Kishida S., and Kikuchi A. Small G protein Ral and its downstream molecules regulate endocytosis of EGF and insulin receptors. EMBO J. 18 (1999) 3629-3642
115. Oosterhoff J.K., Penninkhof F., Brinkmann A.O., Grootegoed J.A., and Blok L.G. POB1 is downregulated during human prostate cancer progression and inhibits growth factor signaling in prostate cancer cells. Oncogene 22 (2003) 2920-2925
116. Yadav S., Zajac E., Singhal S.S., Singhal J., Drake K., Awasthi Y.C., and Awasthi S. POB1 over-expression inhibits RLIP76 mediated transport of glutathione-conjugates, drugs and promotes apoptosis. Biochem. Biophys. Res. Commun. 328 (2005) 1003-1009
117. Shen H.M., and Liu Z.G. JNK signaling pathway is a key modulator in cell death mediated by reactive oxygen and nitrogen species. Free Radic. Biol. Med. 40 (2006) 928-939
118. Saitoh M., Nishitoh H., Fujii M., Takeda K., Tobiume K., Sawada Y., Kawabata M., Miyazono K., and Ichijo H. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J. 17 (1998) 2596-2606
119. Giorgio M., Trinei M., Migliaccio E., and Pelicci P.G. Hydrogen peroxide: a metabolic by-product or a common mediator of ageing signals?. Nat. Rev. Mol. Cell Biol. 8 (2007) 722-728
120. Karin M., and Shaulian E. AP-1: linking hydrogen peroxide and oxidative stress to the control of cell proliferation and death. IUBMB Life 52 (2001) 17-24
121. Wood Z.A., Poole L.B., and Karplus P.A. Peroxiredoxin evolution and the regulation of hydrogen peroxide signaling. Science 300 (2003) 650-653